Aktienanalyse zu Modular Medical Inc (MODD)MODDModular Medical Inc

Modular Medical, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include three parts - one reusable, two disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; removable system, slim profile, lighter weight, and no external controller required, no charging and no battery replacement. Its pump product comprises the pump, a disposable cartridge that holds the insulin reservoir, a baseplate that affixes the pump product to the user's body and the infusion set, which includes a cannula to infuse the insulin into the body. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Modular Medical Inc (MODD) is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $1.33, with an RSI of 24.997 indicating it is oversold. The company has reported a staggering year-to-date change of -88.48% and a 1-year change of -91.30%, reflecting severe declines in stock value. Furthermore, the forward P/E ratio is 0, suggesting no earnings growth is expected in the near future. The main risk is the continued negative net income, which reached -7,790,000 USD in Q2 2026. Given these factors, it is advisable to sell rather than buy at this time.